EFFICACY OF COMBINED CO₂ LASER AND ZINC SULFATE SOLUTION IN TREATING GENITAL WARTS

Văn Tuấn Nguyễn, Huy Lượng Vũ, Huyền My Lê, Thị Liên Nguyễn, Hữu Sáu Nguyễn

Main Article Content

Abstract

Objectives: To evaluate the efficacy of combining laser CO₂ therapy with zinc sulfate solution 0,1% compared to laser CO₂ monotherapy in treating genital warts. Materials and Methods: A randomized controlled trial was conducted on 75 male patients (aged 18–60) with external genital warts at the National Hospital of Dermatology and Venereology from November 2024 to July 2025. Participants were divided into two groups: Group 1 (n=35): Treated with laser CO2 followed by daily zinc sulfate solution 0.1% soak for 12 weeks. Group 2 (n=40): Treated with laser CO2 alone (applied only upon lesion detection). Outcomes included lesion clearance rate at weeks 4, 8, and 12, number of laser sessions required, and adverse effects. Results: Lesion Clearance at 12 Weeks: Group 1: 94.3% clearance Group 2: 87.5% clearance (No significant difference, p > 0.05). Laser Sessions Needed: 74.3% of Group 1 required one session vs 57.5% in Group 2 (p = 0.045). Safety: Mild side effects were comparable; zinc sulfate was well-tolerated. Conclusions: The combination of laser CO₂ and zinc sulfate significantly reduced the number of laser treatments without increasing adverse effects, offering a promising approach for persistent genital warts

Article Details

References

A. Handisurya, C. Schellenbacher, and R. Kirnbauer, "Diseases caused by human papillomaviruses (HPV)," (in engger), J Dtsch Dermatol Ges, vol. 7, no. 5, pp. 453-66; quiz 466, 467, May 2009, doi: 10.1111/j.1610-0387. 2009.06988.x.
2. J. K. Hathaway, "HPV: Diagnosis, Prevention, and Treatment," Clinical Obstetrics and Gynecology, vol. 55, no. 3, pp. 671-680, 2012, doi: 10.1097/GRF.0b013e31825caa36.
3. H. Patel, M. Wagner, P. Singhal, and S. Kothari, "Systematic review of the incidence and prevalence of genital warts," (in eng), BMC Infect Dis, vol. 13, p. 39, Jan 25 2013, doi: 10.1186/1471-2334-13-39.
4. C. O'Mahony et al., "Position statement for the diagnosis and management of anogenital warts," (in eng), J Eur Acad Dermatol Venereol, vol. 33, no. 6, pp. 1006-1019, Jun 2019, doi: 10.1111/jdv.15570.
5. E. A. Moniem, R. M. Genedy, and R. Moussa, "Oral zinc sulfate in the treatment of recalcitrant warts," Egyptian Journal of Dermatology and Venerology, vol. 36, no. 2, 2016. [Online]. Available: https://journals.lww.com/ejdv/fulltext/ 2016/36020/oral_zinc_sulfate_in_the_treatment_of_recalcitrant.2.aspx.
6. H. Ayatollahi, E. Rajabi, Z. Yekta, and Z. Jalali, "Efficacy of Oral Zinc Sulfate Supplementation on Clearance of Cervical Human Papillomavirus (HPV); A Randomized Controlled Clinical Trial," Asian 7. Pacific Journal of Cancer Prevention, vol. 23, no. 4, pp. 1285-1290, 2022, doi: 10.31557/apjcp.2022.23.4.1285.
8. Ala, S. Farhan, F. Cabog, Ficog, and F. Shallal, "Comparison Effect between Imiquimod Cream 5% and Zinc Sulphate Solution 20% in Treatment and Prevention of Recurrence of External Genital Warts," 01/01 2016.
9. L. Tran Hau Thach, D. Le Huu, H. Phuong Quynh, M. Le Huyen, K. Dao Trong, and L. Vu Huy, "Result of treatments of genital warts with laser CO2 according to the risk level of HPV strain," Vietnamese Journal of Dermatology and Venereology, no. 41, 11/09 2023, doi: 10.56320/ tcdlhvn.41.116.
10. S. N. Bae, K. H. Lee, J. H. Kim, S. J. Lee, and L. O. Park, "Zinc induces apoptosis on cervical carcinoma cells by p53-dependent and -independent pathway," Biochemical and Biophysical Research Communications, vol. 484, no. 1, pp. 218-223, 2017/02/26/ 2017, doi: https://doi.org/10.1016/j.bbrc.2016.12.093.